Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CYP27A1 |
| Upstream (Parents) |
|---|
| (<<) FAH → CYP27A1 |
| (<<) C2 → CYP27A1 |
| (<<) APOC1 → CYP27A1 |
| Downstream (Children) |
|---|
| CYP27A1 → FLVCR2 (>>) |
| CYP27A1 → PGP (>>) |
| CYP27A1 → BNIP3 (>>) |
| CYP27A1 → C2 (>>) |
| CYP27A1 → C7orf58 (>>) |
| CYP27A1 → SLC46A3 (>>) |
| CYP27A1 → SLC25A20 (>>) |
| CYP27A1 → MYL4 (>>) |
| CYP27A1 → ZNF280B (>>) |
| CYP27A1 → ADRA1A (>>) |
| CYP27A1 → CHI3L1 (>>) |
| CYP27A1 → PVALB (>>) |
| CYP27A1 → NDUFA4L2 (>>) |
| CYP27A1 → BBS7 (>>) |
| CYP27A1 → MYL10 (>>) |
| CYP27A1 → FAM50B (>>) |
| CYP27A1 → GCHFR (>>) |
| CYP27A1 → FCGRT (>>) |
| CYP27A1 → ACYP1 (>>) |
| CYP27A1 → HOMER1 (>>) |
| CYP27A1 → FAM86A (>>) |
| CYP27A1 → ABHD8 (>>) |
| CYP27A1 → LILRA5 (>>) |
| CYP27A1 → CSNK1E (>>) |
| CYP27A1 → CSPG5 (>>) |
